Predict your next investment

Stellartech Research company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
stellartechresearch.com

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Stellartech Research

Stellartech Research is a medical device company. It had developed the Stellartech 100 Coagulation System. Stellartech Research Corporation - Innovative Outsourcing Solutions.

Stellartech Research Headquarter Location

1350 Bordeaux Drive

Sunnyvale, California, 94089,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Stellartech Research Investments

1 Investments

Stellartech Research has made 1 investments. Their latest investment was in BARRx Medical as part of their Series A on April 4, 2003.

CBI Logo

Stellartech Research Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/23/2003

Series A

BARRx Medical

$6.8M

Yes

Date

4/23/2003

Round

Series A

Company

BARRx Medical

Amount

$6.8M

New?

Yes

Co-Investors

Sources

Stellartech Research Portfolio Exits

1 Portfolio Exit

Stellartech Research has 1 portfolio exit. Their latest portfolio exit was BARRx Medical on November 21, 2011.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/21/2011

Acquired

$991

4

Date

11/21/2011

Exit

Acquired

Companies

Valuation

$991

Acquirer

Sources

4

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.